John Wiley & Sons Inc

John Wiley & Sons Inc (WLYB) Stock Analysis

$52.528

+0.956 (+1.82%)At close

Loading chart…
High
52.528
Open
52.528
VWAP
52.53
Volume
154.00
Mkt Cap
2.24B
Low
52.528
Amount
8.09K
EV/EBITDA, TTM
13.91

John Wiley & Sons, Inc., is a publisher. The Company's content, services, platforms, and knowledge networks are tailored to meet the needs of its customers and partners, including researchers, students, instructors, professionals, institutions, and corporations. Its segments include Research, Learning and Held for Sale or Sold. Research segment provides peer-reviewed scientific, technical, and medical (STM) publishing, content platforms, and related services to academic, corporate, and government customers, academic societies, and individual researchers. Its journal publishing categories include the social sciences and humanities, and life sciences. Learning segment provides scientific, professional, and education print and digital books, digital courseware to libraries, corporations, students, professionals, and researchers, as well as assessment services to businesses and professionals. Its operations are located in the United States, United Kingdom, India, Sri Lanka, and Germany.

www.wiley.com

AI analysis of John Wiley & Sons Inc (WLYB)

Buy

John Wiley & Sons Inc is a good buy right now due to its current price of $52.53, a strong RSI of 85.914 indicating overbought conditions, and a significant year-to-date change of +68.47%. The company also reported a gross margin of 72.47% in its latest quarter, reflecting strong profitability. However, the main risk is its recent net income drop to -11.7 million in Q1 2027, which could affect future performance.

Valuation Metrics

The current forward P/E ratio for John Wiley & Sons Inc (WLYB) is 15.67, compared to its 5-year average forward P/E of 12.86.

Forward P/E

Fair
5Y Average P/E
12.86
Current P/E
15.67
Overvalued
16.32
Undervalued
9.39

Forward EV/EBITDA

Strongly Overvalued
5Y Average EV/EBITDA
8.05
Current EV/EBITDA
13.91
Overvalued
9.48
Undervalued
6.61

Forward P/S

Overvalued
5Y Average P/S
1.25
Current P/S
1.44
Overvalued
1.43
Undervalued
1.08

Alphio AI Price Scenarios for WLYB

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%WLYB

$41.33

Scenario price

B

Base

Base · 50%WLYB

$35.93

Scenario price

B

Bear

Bear · 25%WLYB

$34.24

Scenario price

WLYB FAQ — answered by Alphio AI

John Wiley & Sons, Inc., is a publisher. The Company's content, services, platforms, and knowledge networks are tailored to meet the needs of its customers and partners, including researchers, students, instructors, professionals, institutions, and corporations. Its segments include Research, Learning and Held for Sale or Sold. Research segment provides peer-reviewed scientific, technical, and medical (STM) publishing, content platforms, and related services to academic, corporate, and government customers, academic societies, and individual researchers. Its journal publishing categories include the social sciences and humanities, and life sciences. Learning segment provides scientific, professional, and education print and digital books, digital courseware to libraries, corporations, students, professionals, and researchers, as well as assessment services to businesses and professionals. Its operations are located in the United States, United Kingdom, India, Sri Lanka, and Germany. It operates in the Consumer Cyclicals sector (BOOKS: PUBLISHING OR PUBLISHING & PRINTING industry).

John Wiley & Sons Inc is a good buy right now due to its current price of $52.53, a strong RSI of 85.914 indicating overbought conditions, and a significant year-to-date change of +68.47%. The company also reported a gross margin of 72.47% in its latest quarter, reflecting strong profitability. However, the main risk is its recent net income drop to -11.7 million in Q1 2027, which could affect future performance.

Community

More ↗

No posts yet

Sign up or log in to join the discussion

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Start trading